NEW YORK (GenomeWeb News) – Cancer geneticist Janet Rowley has died at the age of 88, according to the University of Chicago, where she discovered genetic aberrations involved in leukemia, which led to new treatments such as Gleevec (imatinib).

The University noted this week that Rowley made a series of fundamental discoveries during her career that demonstrated how specific chromosomal changes caused certain types of cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.